Thus, because RPX could not demonstrate that it had suffered an injury in fact, the Court held that RPX lacked Article III standing to appeal the PTAB’s decision affirming the patentability of ChanBond’s patented claims.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.